NEPHROS, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
NEPHROS, INC. (NEPH) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $4.70 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2026-08-10
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $4.70M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $4.02M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $5.40M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $5.17M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations |
|---|---|
| 2026-06-30 | $4.70M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $4.02M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $5.40M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $5.17M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $5.07M 10-Q · filed 2026-08-10 |
| 2025-03-31 | $4.08M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $3.76M 10-Q · filed 2026-08-10 |
| 2024-09-30 | $2.46M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $3.08M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $3.63M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $4.31M 10-K · filed 2026-03-12 |
| 2023-09-30 | $4.62M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $4.06M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $3.84M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $3.63M 10-K · filed 2025-03-24 |
| 2022-09-30 | $3.94M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $4.18M 10-Q · filed 2023-08-09 |
| 2022-03-31 | $5.42M 10-Q · filed 2023-05-10 |
| 2021-12-31 | $6.97M 10-K · filed 2024-03-15 |
| 2021-09-30 | $7.35M 10-Q · filed 2022-11-15 |
| 2021-06-30 | $8.28M 10-Q · filed 2022-08-15 |
| 2021-03-31 | $8.16M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $8.25M 10-K · filed 2023-03-23 |
| 2020-09-30 | $5.16M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $7.05M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $8.96M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $4.17M 10-K · filed 2022-03-03 |
| 2019-09-30 | $3.85M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $4.32M 10-Q · filed 2020-08-05 |
| 2019-03-31 | $3.61M 10-Q · filed 2020-05-06 |
| 2018-12-31 | $4.58M 10-K · filed 2021-03-01 |
| 2018-09-30 | $5.32M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $3.48M 10-Q · filed 2019-08-07 |
| 2017-12-31 | $2.19M 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |